Tuesday Poster Session
Category: Esophagus
Prabhat Kumar, MD
Cleveland Clinic Foundation
Cleveland, OH
Parameters | Achalasia (%) | No Achalasia (%) | Odds Ratio | 95% CI | p-valve | |
Age (in years) | Age 18-65 | 12,200 (39.61) | 47,728,940 (68.7) | 0.30 | 0.29 to 0.30 | < 0.0001 |
Age >65 | 18,130 (58.8) | 20,561,080 (29.5) | 3.40 | 3.33 to 3.48 | < 0.0001 | |
Gender | Male | 13,370 (43.4) | 30,943,050 (44.54) | 0.95 | 0.93 to 0.98 | = 0.0001 |
Female | 17,320 (56.2) | 38,041,540 (54.75) | 1.06 | 1.04 to 1.08 | < 0.0001 | |
Race | White | 23,190 (75.3) | 37,372,370 (53.7) | 2.62 | 2.55 to 2.69 | < 0.0001 |
African American | 3,570 (11.6) | 7,024,100 (10.11) | 1.16 | 1.12 to 1.21 | < 0.0001 | |
Asian | 400 (1.2) | 1,125,480 (1.62) | 0.80 | 0.72 to 0.88 | < 0.0001 | |
Hispanic | 180 (0.6) | 897,860 (1.29) | 0.45 | 0.39 to 0.52 | < 0.0001 | |
Malignancies | Esophageal cancer | 420 (1.36) | 37,210 (0.05) | 25.78 | 23.42 to 28.42 | < 0.0001 |
Breast cancer | 1,130 (3.66) | 711,650 (1.02) | 3.68 | 3.47 to 3.90 | < 0.0001 | |
Lung cancer | 650 (2.11) | 315,620 (0.45) | 4.72 | 4.37 to 5.10 | < 0.0001 | |
Thyroid cancer | 180 (0.58) | 98,980 (0.14) | 4.12 | 3.56 to 4.77 | < 0.0001 | |
Gastric cancer | 220 (0.71) | 34,200 (0.04) | 14.61 | 12.79 to 16.68 | < 0.0001 | |
Hepatocellular Carcinoma | 120 (0.38) | 60,300 (0.08) | 4.50 | 3.76 to 5.39 | < 0.0001 | |
Cholangiocarcinoma | 50 (0.16) | 90 (0.00012) | 1255.13 | 888.11 to 1773.81 | < 0.0001 | |
Colon Cancer | 470 (1.52) | 241,280 (0.34) | 4.45 | 4.06 to 4.87 | < 0.0001 |